Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

EIF4E anticorps

EIF4E Reactivité: Humain WB, IHC, ELISA, FACS, ICC Hôte: Souris Monoclonal 5D11 unconjugated
N° du produit ABIN969094
  • Antigène Voir toutes EIF4E Anticorps
    EIF4E (Eukaryotic Translation Initiation Factor 4E (EIF4E))
    Reactivité
    • 122
    • 63
    • 51
    • 19
    • 5
    • 5
    • 5
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    Humain
    Hôte
    • 105
    • 16
    • 2
    Souris
    Clonalité
    • 98
    • 25
    Monoclonal
    Conjugué
    • 56
    • 9
    • 8
    • 6
    • 6
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    Cet anticorp EIF4E est non-conjugé
    Application
    • 95
    • 49
    • 39
    • 27
    • 26
    • 26
    • 16
    • 14
    • 14
    • 13
    • 7
    • 6
    • 2
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), ELISA, Flow Cytometry (FACS), Immunocytochemistry (ICC)
    Fonction
    EIF4E Antibody
    Purification
    Ascitic fluid
    Immunogène
    Purified recombinant fragment of human EIF4E expressed in E. Coli.
    Clone
    5D11
    Isotype
    IgG1
    Top Product
    Discover our top product EIF4E Anticorps primaire
  • Indications d'application

    ELISA: 1/10000

    FCM: 1/200 - 1/400

    ICC: 1/200 - 1/1000

    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Ascitic fluid containing 0.03 % sodium azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C,-20 °C
    Stockage commentaire
    Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
  • Slepenkov, Korneeva, Rhoads: "Kinetic mechanism for assembly of the m7GpppG.eIF4E.eIF4G complex." dans: The Journal of biological chemistry, Vol. 283, Issue 37, pp. 25227-37, (2008) (PubMed).

    Holm, Byrnes, Johnson, Abreo, Sehon, Alley, Meschonat, Md, Li: "A prospective trial on initiation factor 4E (eIF4E) overexpression and cancer recurrence in node-negative breast cancer." dans: Annals of surgical oncology, Vol. 15, Issue 11, pp. 3207-15, (2008) (PubMed).

  • Antigène
    EIF4E (Eukaryotic Translation Initiation Factor 4E (EIF4E))
    Autre désignation
    EIF4E (EIF4E Produits)
    Sujet

    Description: eIF4E, a protein modulates translation of maternal mRNAs in early embryos before the onset of zygotic transcription. eIF4E also influences the overall rate of translation. eIF4E binds to the 7 methyl GTP cap structure of eukaryotic mRNAs. Phosphorylation of eIF4E on serine 209 regulates the affinity of this protein for the 7 methyl GTP cap and/or RNA. Phosphorylation also enhances the interaction of eIF4E with eIF4G, which form a complex known as eIF4F. eIF4E phosphorylation is correlated with increased translational rate in a number of cell types. Several kinases are currently being investigated as potential regulators of eIF4E including PKC and/or the MAP kinase activated Mnk.

    Aliases: CBP, EIF4F, EIF4E1, EIF4EL1, MGC111573, EIF4E

    Poids moléculaire
    25kDa
    ID gène
    1977
    HGNC
    1977
    UniProt
    P06730
    Pathways
    BCR Signaling
Support technique
Close menu